SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-003779
Filing Date
2024-05-22
Accepted
2024-05-22 17:00:16
Documents
16
Period of Report
2024-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm   iXBRL 8-K 33212
2 PRESS RELEASE xenetic_ex9901.htm EX-99.1 13103
7 GRAPHIC image_001.gif GRAPHIC 5333
  Complete submission text file 0001683168-24-003779.txt   274295

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xbio-20240516.xsd EX-101.SCH 3728
4 XBRL DEFINITION FILE xbio-20240516_def.xml EX-101.DEF 26553
5 XBRL LABEL FILE xbio-20240516_lab.xml EX-101.LAB 36560
6 XBRL PRESENTATION FILE xbio-20240516_pre.xml EX-101.PRE 25177
19 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 5432
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 24974184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)